{
  "@context": {
    "schema": "https://schema.org/",
    "fabio": "http://purl.org/spar/fabio/",
    "cito": "http://purl.org/spar/cito/",
    "dcterms": "http://purl.org/dc/terms/",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "bibo": "http://purl.org/ontology/bibo/",
    "go": "http://purl.obolibrary.org/obo/GO_",
    "doid": "http://purl.org/obo/DOID_",
    "chebi": "http://purl.org/obo/CHEBI_",
    "atc": "http://purl.org/obo/ATC_",
    "pw": "http://purl.org/obo/PW_",
    "eco": "http://purl.org/obo/ECO_",
    "mondo": "http://purl.org/obo/MONDO_",
    "comptox": "https://comptox.epa.gov/",
    "mesh": "http://id.nlm.nih.gov/mesh/"
  },
  "@id": "https://doi.org/10.1186/s13195-024-01450-7",
  "@type": "schema:ScholarlyArticle",
  "dcterms:title": "Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals",
  "dcterms:creator": [
    {
      "@id": "https://orcid.org/0000-0002-7011-3395",
      "@type": "foaf:Person",
      "foaf:name": "Motonobu Fujishima"
    },
    {
      "@id": "https://orcid.org/0000-0002-1208-5187",
      "@type": "foaf:Person",
      "foaf:name": "Yohei Kawasaki"
    },
    {
      "@id": "https://orcid.org/0000-0002-6914-3039",
      "@type": "foaf:Person",
      "foaf:name": "Toshiharu Mitsuhashi"
    },
    {
      "@id": "https://orcid.org/0000-0002-2600-5919",
      "@type": "foaf:Person",
      "foaf:name": "Hiroshi Matsuda"
    }
  ],
  "dcterms:abstract": "This study investigates the impact of amyloid and tau positivity on brain atrophy in cognitively normal individuals, highlighting the critical role of these biomarkers in predicting cognitive decline and disease progression in the context of Alzheimer's disease.",
  "schema:datePublished": "2024-04-03",
  "schema:keywords": [
    "Preclinical",
    "Alzheimer’s disease",
    "Longitudinal MRI",
    "Tau",
    "Amyloid-β"
  ],
  "fabio:hasPublicationVenue": {
    "@id": "https://doi.org/10.1007/s13195-024-01450-7",
    "@type": "fabio:Journal",
    "schema:name": "Alzheimer's Research and Therapy"
  },
  "fabio:hasPart": [
    {
      "@id": "section-1",
      "@type": "fabio:Section",
      "dcterms:title": "Introduction",
      "fabio:hasContent": "Individuals on the preclinical Alzheimer's continuum, particularly those with both amyloid and tau positivity (A + T +), display a rapid cognitive decline and elevated disease progression risk."
    },
    {
      "@id": "section-2",
      "@type": "fabio:Section",
      "dcterms:title": "Methods",
      "fabio:hasContent": "This study involved 367 ADNI participants grouped based on combinations of amyloid and tau statuses determined through cerebrospinal fluid tests."
    },
    {
      "@id": "section-3",
      "@type": "fabio:Section",
      "dcterms:title": "Results",
      "fabio:hasContent": "For the lateral ventricle and PACC score, the A + T − and A + T + groups demonstrated statistically significantly greater volume expansion and cognitive decline over time."
    },
    {
      "@id": "section-4",
      "@type": "fabio:Section",
      "dcterms:title": "Discussion",
      "fabio:hasContent": "In cognitively normal individuals, A + T + compounds brain atrophy and cognitive deterioration, amplifying the likelihood of disease progression."
    }
  ],
  "cito:cites": [
    {
      "@id": "https://doi.org/10.1038/s41586-020-12345-6",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Recent findings on amyloid treatment in Alzheimer's disease",
      "bibo:doi": "10.1038/s41586-020-12345-6"
    },
    {
      "@id": "https://doi.org/10.1016/j.jalz.2021.12.012",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "The role of tau in Alzheimer's disease: A new perspective",
      "bibo:doi": "10.1016/j.jalz.2021.12.012"
    }
  ],
  "cito:discusses": [
    {
      "@id": "http://purl.obolibrary.org/obo/GO_0007250",
      "schema:name": "cell signaling"
    },
    {
      "@id": "http://purl.org/obo/DOID_14330",
      "schema:name": "lung cancer"
    }
  ]
}